<clinical_study>
  <!-- This xml conforms to an XML Schema at:
    https://clinicaltrials.gov/ct2/html/images/info/public.xsd -->
  <required_header>
    <download_date>ClinicalTrials.gov processed this data on November 19, 2021</download_date>
    <link_text>Link to the current ClinicalTrials.gov record.</link_text>
    <url>https://clinicaltrials.gov/show/NCT02967315</url>
  </required_header>
  <id_info>
    <org_study_id>2018-0399</org_study_id>
    <secondary_id>2013-0276</secondary_id>
    <secondary_id>SMPH/SURGERY/CARDIOTHORACIC</secondary_id>
    <nct_id>NCT02967315</nct_id>
  </id_info>
  <brief_title>Effects of Changes in Fluid Status on Right Ventricular Volumes and Function</brief_title>
  <official_title>Effects of Changes in Fluid Status on Right Ventricular Volumes and Function</official_title>
  <sponsors>
    <lead_sponsor>
      <agency>University of Wisconsin, Madison</agency>
      <agency_class>Other</agency_class>
    </lead_sponsor>
  </sponsors>
  <source>University of Wisconsin, Madison</source>
  <oversight_info>
    <has_dmc>No</has_dmc>
  </oversight_info>
  <brief_summary>
    <textblock>
      The purpose of this study is to evaluate the correlation between fluid volume status and&#xD;
      right ventricular volume and function, in those with free pulmonary valve insufficiency after&#xD;
      Tetralogy of Fallot (TOF) repair.&#xD;
    </textblock>
  </brief_summary>
  <detailed_description>
    <textblock>
      The purpose of this study is to measure the changes in Right Ventricular size and function&#xD;
      with changes in preload, using cardiovascular magnetic resonance (CMR). Based on an intensive&#xD;
      research and clinical observations the investigators hypothesize that changes in volume&#xD;
      status cause a statistically significant difference in the Cardiovascular magnetic resonance&#xD;
      (CMR) measured RV End Diastolic Volume (EDV), end-systolic volume (ESV), ejection fraction&#xD;
      (EF) and pulmonary regurgitation (PR). The investigator hypothesizes that smaller changes&#xD;
      will occur in left ventricular LV EDV, ESV, and EF.&#xD;
&#xD;
        1. To establish a correlation between the changes in preload volume status and RV size and&#xD;
           function in patients with free pulmonary insufficiency (PI) after TOF repair using CMRI.&#xD;
&#xD;
        2. To assess the effects of preload status on the measured severity of pulmonary&#xD;
           regurgitation (PR).&#xD;
&#xD;
        3. To assess the effects of preload status on the left ventricular (LV) size&#xD;
&#xD;
      This study will be conducted in compliance with this protocol, good clinical practice and the&#xD;
      applicable regulatory requirements.&#xD;
    </textblock>
  </detailed_description>
  <overall_status>Completed</overall_status>
  <start_date type="Actual">June 6, 2014</start_date>
  <completion_date type="Actual">March 18, 2021</completion_date>
  <primary_completion_date type="Actual">March 18, 2021</primary_completion_date>
  <phase>N/A</phase>
  <study_type>Interventional</study_type>
  <has_expanded_access>No</has_expanded_access>
  <study_design_info>
    <allocation>N/A</allocation>
    <intervention_model>Single Group Assignment</intervention_model>
    <primary_purpose>Diagnostic</primary_purpose>
    <masking>None (Open Label)</masking>
  </study_design_info>
  <primary_outcome>
    <measure>Postload volume status</measure>
    <time_frame>24 months</time_frame>
    <description>The following will be measured to define the postload volume status: Left and right ventricle end diastolic volume (milliliters [ml]); Ejection fraction (%); pulmonary regurgitation</description>
  </primary_outcome>
  <number_of_arms>1</number_of_arms>
  <enrollment type="Actual">4</enrollment>
  <condition>Tetralogy of Fallot</condition>
  <arm_group>
    <arm_group_label>Study Group</arm_group_label>
    <arm_group_type>Experimental</arm_group_type>
    <description>Procedures include:&#xD;
Two Cardiac Magnetic Resonance Imaging (CMRIs) A central venous line placement, A chest X-ray Electrocardiogram (ECG) Fluid administration Blood draw Pregnancy test</description>
  </arm_group>
  <intervention>
    <intervention_type>Procedure</intervention_type>
    <intervention_name>Cardiac Magnetic Resonance Imaging (CMRI)</intervention_name>
    <description>There will be 2 CMRIs. The first one will be patient's routine clinically schedule CMRI after the patient has fasted for 12 hours.This CMRI uses contrast.&#xD;
The second CMRI will be the research CMRI after the fluid administration. This CMRI does not use contrast.</description>
    <arm_group_label>Study Group</arm_group_label>
  </intervention>
  <intervention>
    <intervention_type>Procedure</intervention_type>
    <intervention_name>Central venous line placement</intervention_name>
    <description>An ultrasound guided central line catheter will be placed in the internal jugular vein (IJV) under local anesthesia.</description>
    <arm_group_label>Study Group</arm_group_label>
  </intervention>
  <intervention>
    <intervention_type>Procedure</intervention_type>
    <intervention_name>Chest X-ray</intervention_name>
    <description>A chest X-ray will be performed for safety reasons to rule out pneumothorax (&lt; 1% risk) after central line placement.</description>
    <arm_group_label>Study Group</arm_group_label>
  </intervention>
  <intervention>
    <intervention_type>Procedure</intervention_type>
    <intervention_name>Fluid administration</intervention_name>
    <description>Administration of 15cc/kg of normal saline for fluid hydration through peripheral IV that is placed for the MRI contrast administration.</description>
    <arm_group_label>Study Group</arm_group_label>
  </intervention>
  <intervention>
    <intervention_type>Procedure</intervention_type>
    <intervention_name>Blood Draw</intervention_name>
    <description>One to two teaspoons of blood will be drawn for basic metabolic panel.</description>
    <arm_group_label>Study Group</arm_group_label>
  </intervention>
  <intervention>
    <intervention_type>Procedure</intervention_type>
    <intervention_name>Pregnancy test</intervention_name>
    <description>A urine pregnancy test will be performed in female subjects.</description>
    <arm_group_label>Study Group</arm_group_label>
  </intervention>
  <intervention>
    <intervention_type>Procedure</intervention_type>
    <intervention_name>Electrocardiogram</intervention_name>
    <description>12 lead ECG</description>
    <arm_group_label>Study Group</arm_group_label>
  </intervention>
  <eligibility>
    <criteria>
      <textblock>
        Inclusion Criteria:&#xD;
&#xD;
          1. TOF patients who have had repair using a transannular patch.&#xD;
&#xD;
          2. Patients that present with free pulmonary insufficiency.&#xD;
&#xD;
          3. Are older than 18 years.&#xD;
&#xD;
        Exclusion Criteria:&#xD;
&#xD;
          1. Patients who have lesions predisposing to chronic volume overload (i.e. patients with&#xD;
             significant residual postoperative ventricular septal defects (VSD), or large&#xD;
             aorto-pulmonary collaterals or more than moderate tricuspid insufficiency) since all&#xD;
             these hemodynamic conditions can influence the late function of the right ventricle&#xD;
             and potentially affect the response of the right side of the heart in changes in&#xD;
             volume status&#xD;
&#xD;
          2. Patients who had a valve sparing TOF repair and have less than free pulmonary&#xD;
             insufficiency.&#xD;
&#xD;
          3. Patients who have significant residual right-sided obstruction (i.e. patients who have&#xD;
             residual RVOT obstruction or significant residual branch pulmonary artery stenosis),&#xD;
             as it is shown that residual pulmonary stenosis may protect from RV dilation and from&#xD;
             deterioration of the RV function.&#xD;
&#xD;
          4. Patients who cannot be reconstructed with a transannular patch and/or require a right&#xD;
             ventricle to pulmonary artery homograft for reconstruction including:&#xD;
&#xD;
               -  pulmonary atresia and VSD&#xD;
&#xD;
               -  patients with anomalous coronary crossing the right ventricular outflow tract&#xD;
                  (RVOT) and&#xD;
&#xD;
               -  patients with TOF-absent pulmonary valve syndrome.&#xD;
&#xD;
          5. Patients with renal failure and renal insufficiency&#xD;
&#xD;
          6. Patients with uncompensated heart failure&#xD;
&#xD;
          7. Cancer patients&#xD;
&#xD;
          8. Latex allergic patients&#xD;
&#xD;
          9. Patients with diabetes&#xD;
&#xD;
         10. Pregnant females&#xD;
&#xD;
         11. Prisoners&#xD;
&#xD;
         12. Individuals who lack consent capacity&#xD;
      </textblock>
    </criteria>
    <gender>All</gender>
    <minimum_age>18 Years</minimum_age>
    <maximum_age>N/A</maximum_age>
    <healthy_volunteers>No</healthy_volunteers>
  </eligibility>
  <overall_official>
    <last_name>Petros V Anagnostopoulos, MD</last_name>
    <role>Principal Investigator</role>
    <affiliation>University of Wisconsin, Madison</affiliation>
  </overall_official>
  <location>
    <facility>
      <name>University of Wisconsin-Madison</name>
      <address>
        <city>Madison</city>
        <state>Wisconsin</state>
        <zip>53792</zip>
        <country>United States</country>
      </address>
    </facility>
  </location>
  <location_countries>
    <country>United States</country>
  </location_countries>
  <verification_date>April 2021</verification_date>
  <study_first_submitted>October 27, 2016</study_first_submitted>
  <study_first_submitted_qc>November 15, 2016</study_first_submitted_qc>
  <study_first_posted type="Estimate">November 18, 2016</study_first_posted>
  <last_update_submitted>April 9, 2021</last_update_submitted>
  <last_update_submitted_qc>April 9, 2021</last_update_submitted_qc>
  <last_update_posted type="Actual">April 14, 2021</last_update_posted>
  <responsible_party>
    <responsible_party_type>Sponsor</responsible_party_type>
  </responsible_party>
  <condition_browse>
    <!-- CAUTION:  The following MeSH terms are assigned with an imperfect algorithm            -->
    <mesh_term>Tetralogy of Fallot</mesh_term>
  </condition_browse>
  <patient_data>
    <sharing_ipd>No</sharing_ipd>
  </patient_data>
  <!-- Results have not yet been posted for this study                                          -->
</clinical_study>

